US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 1.160
  • +0.010+0.87%
Close Jul 26 16:00 ET
  • 1.160
  • 0.0000.00%
Post 19:46 ET
85.05MMarket Cap14.50P/E (TTM)

Protalix Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
239.69%4.19M
94.73%-1.32M
237.69%3.6M
25.16%-6.89M
167.60%4.97M
48.57%-3M
-143.07%-25M
48.67%-2.61M
-389.57%-9.2M
-212.89%-7.36M
Net income from continuing operations
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
45.88%-14.93M
43.90%-3.74M
15.05%-3.57M
52.55%-5.33M
Operating gains losses
-75.00%5K
92.96%-38K
139.35%61K
-325.00%-108K
97.88%-11K
-76.47%20K
-166.42%-540K
-2,037.50%-155K
-94.30%48K
-3,600.00%-518K
Depreciation and amortization
15.00%322K
9.67%1.19M
13.82%313K
11.72%305K
9.33%293K
3.70%280K
-2.86%1.09M
6.18%275K
-4.21%273K
-6.94%268K
Deferred tax
---138K
---3.09M
--0
--38K
---3.13M
--0
--0
--0
----
----
Other non cash items
-4,181.82%-471K
12.92%-600K
-27.06%124K
-464.15%-299K
39.39%-414K
91.06%-11K
-122.30%-689K
-57.82%170K
-106.02%-53K
-166.31%-683K
Change In working capital
1,251.57%8.08M
12.28%-10.54M
2,491.33%7.77M
4.08%-6.07M
-738.20%-11.54M
84.78%-702K
-221.35%-12.02M
-39.02%300K
-2,420.72%-6.33M
-108.67%-1.38M
-Change in receivables
-54.33%1.75M
64.15%-428K
-16.41%3.76M
25.33%-4.31M
-254.98%-3.7M
265.21%3.82M
-15.70%-1.19M
47.81%4.5M
-131.83%-5.77M
243.88%2.39M
-Change in inventory
5.66%-3.3M
-294.87%-2.24M
213.20%2.54M
-200.15%-1.95M
667.82%668K
-357.28%-3.5M
123.60%1.15M
30.46%-2.24M
278.44%1.95M
-68.36%87K
-Change in payables and accrued expense
-500.57%-1.41M
210.22%5.3M
503.01%1.48M
-58.45%177K
185.39%3.29M
134.92%353K
-301.43%-4.8M
-127.83%-366K
-73.61%426K
-244.33%-3.85M
-Change in other current assets
55.56%14K
360.00%13K
-96.00%1K
133.33%9K
---6K
--9K
-102.07%-5K
-65.75%25K
-136.49%-27K
----
-Change in other current liabilities
----
--0
----
----
----
----
--0
----
----
----
-Change in other working capital
895.32%11.04M
-84.00%-13.18M
--0
--0
-589,600.00%-11.79M
47.54%-1.39M
-154.13%-7.16M
-125.87%-1.62M
-273.11%-2.9M
-99.99%2K
Cash from discontinued investing activities
Operating cash flow
239.69%4.19M
94.73%-1.32M
237.69%3.6M
25.16%-6.89M
167.60%4.97M
48.57%-3M
-143.07%-25M
48.67%-2.61M
-389.57%-9.2M
-212.89%-7.36M
Investing cash flow
Cash flow from continuing investing activities
-112.81%-606K
-231.90%-16.71M
-106.90%-342K
-453.16%-20.88M
-162.18%-222K
129.11%4.73M
-126.61%-5.04M
-86.77%4.95M
27.72%5.91M
-95.27%357K
Net PPE purchase and sale
-141.13%-598K
-82.96%-1.15M
-17.37%-250K
-670.69%-447K
-59.38%-204K
-8.30%-248K
55.33%-628K
52.46%-213K
83.14%-58K
54.45%-128K
Net investment purchase and sale
----
-208.40%-15.42M
--0
-440.33%-20.42M
--0
131.25%5M
-125.00%-5M
-86.78%5M
20.00%6M
--0
Net other investing changes
60.00%-8K
-123.95%-142K
-155.42%-92K
60.00%-12K
-103.71%-18K
28.57%-20K
81.35%593K
238.78%166K
-11.11%-30K
51.09%485K
Cash from discontinued investing activities
Investing cash flow
-112.81%-606K
-231.90%-16.71M
-106.90%-342K
-453.16%-20.88M
-162.18%-222K
129.11%4.73M
-126.61%-5.04M
-86.77%4.95M
27.72%5.91M
-95.27%357K
Financing cash flow
Cash flow from continuing financing activities
0
199.42%24.67M
0
0
10.43M
14.23M
-31.79%8.24M
200.72%4.08M
105.85%1.52M
Net issuance payments of debt
----
--0
----
----
----
----
--0
----
----
----
Net common stock issuance
--0
190.85%23.95M
--0
--0
--9.72M
--14.23M
-82.17%8.24M
--4.08M
--1.52M
----
Proceeds from stock option exercised by employees
----
35,500.00%712K
--0
--0
----
----
--2K
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
--0
199.42%24.67M
--0
--0
294.74%10.43M
--14.23M
-31.79%8.24M
200.72%4.08M
105.85%1.52M
--2.64M
Net cash flow
Beginning cash position
38.12%23.63M
-56.11%17.11M
90.37%20.41M
285.72%48.18M
95.62%33.04M
-56.11%17.11M
113.44%38.99M
0.73%10.72M
-63.13%12.49M
-14.84%16.89M
Current changes in cash
-77.57%3.58M
130.45%6.64M
-49.31%3.25M
-1,466.99%-27.77M
448.58%15.18M
172.29%15.97M
-205.23%-21.8M
-77.33%6.42M
92.38%-1.77M
-130.99%-4.36M
Effect of exchange rate changes
83.33%-7K
-48.05%-114K
-3.85%-27K
---9K
10.00%-36K
-281.82%-42K
-1,383.33%-77K
-165.00%-26K
--0
-900.00%-40K
End cash Position
-17.64%27.21M
38.12%23.63M
38.12%23.63M
90.37%20.41M
285.72%48.18M
95.62%33.04M
-56.11%17.11M
-56.11%17.11M
0.73%10.72M
-63.13%12.49M
Free cash flow
210.60%3.59M
90.37%-2.47M
218.45%3.35M
20.81%-7.34M
163.72%4.77M
46.42%-3.25M
-118.22%-25.63M
48.98%-2.82M
-316.46%-9.26M
-220.03%-7.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 239.69%4.19M94.73%-1.32M237.69%3.6M25.16%-6.89M167.60%4.97M48.57%-3M-143.07%-25M48.67%-2.61M-389.57%-9.2M-212.89%-7.36M
Net income from continuing operations -46.76%-4.6M155.68%8.31M-61.60%-6.04M48.08%-1.85M462.56%19.34M-36.96%-3.13M45.88%-14.93M43.90%-3.74M15.05%-3.57M52.55%-5.33M
Operating gains losses -75.00%5K92.96%-38K139.35%61K-325.00%-108K97.88%-11K-76.47%20K-166.42%-540K-2,037.50%-155K-94.30%48K-3,600.00%-518K
Depreciation and amortization 15.00%322K9.67%1.19M13.82%313K11.72%305K9.33%293K3.70%280K-2.86%1.09M6.18%275K-4.21%273K-6.94%268K
Deferred tax ---138K---3.09M--0--38K---3.13M--0--0--0--------
Other non cash items -4,181.82%-471K12.92%-600K-27.06%124K-464.15%-299K39.39%-414K91.06%-11K-122.30%-689K-57.82%170K-106.02%-53K-166.31%-683K
Change In working capital 1,251.57%8.08M12.28%-10.54M2,491.33%7.77M4.08%-6.07M-738.20%-11.54M84.78%-702K-221.35%-12.02M-39.02%300K-2,420.72%-6.33M-108.67%-1.38M
-Change in receivables -54.33%1.75M64.15%-428K-16.41%3.76M25.33%-4.31M-254.98%-3.7M265.21%3.82M-15.70%-1.19M47.81%4.5M-131.83%-5.77M243.88%2.39M
-Change in inventory 5.66%-3.3M-294.87%-2.24M213.20%2.54M-200.15%-1.95M667.82%668K-357.28%-3.5M123.60%1.15M30.46%-2.24M278.44%1.95M-68.36%87K
-Change in payables and accrued expense -500.57%-1.41M210.22%5.3M503.01%1.48M-58.45%177K185.39%3.29M134.92%353K-301.43%-4.8M-127.83%-366K-73.61%426K-244.33%-3.85M
-Change in other current assets 55.56%14K360.00%13K-96.00%1K133.33%9K---6K--9K-102.07%-5K-65.75%25K-136.49%-27K----
-Change in other current liabilities ------0------------------0------------
-Change in other working capital 895.32%11.04M-84.00%-13.18M--0--0-589,600.00%-11.79M47.54%-1.39M-154.13%-7.16M-125.87%-1.62M-273.11%-2.9M-99.99%2K
Cash from discontinued investing activities
Operating cash flow 239.69%4.19M94.73%-1.32M237.69%3.6M25.16%-6.89M167.60%4.97M48.57%-3M-143.07%-25M48.67%-2.61M-389.57%-9.2M-212.89%-7.36M
Investing cash flow
Cash flow from continuing investing activities -112.81%-606K-231.90%-16.71M-106.90%-342K-453.16%-20.88M-162.18%-222K129.11%4.73M-126.61%-5.04M-86.77%4.95M27.72%5.91M-95.27%357K
Net PPE purchase and sale -141.13%-598K-82.96%-1.15M-17.37%-250K-670.69%-447K-59.38%-204K-8.30%-248K55.33%-628K52.46%-213K83.14%-58K54.45%-128K
Net investment purchase and sale -----208.40%-15.42M--0-440.33%-20.42M--0131.25%5M-125.00%-5M-86.78%5M20.00%6M--0
Net other investing changes 60.00%-8K-123.95%-142K-155.42%-92K60.00%-12K-103.71%-18K28.57%-20K81.35%593K238.78%166K-11.11%-30K51.09%485K
Cash from discontinued investing activities
Investing cash flow -112.81%-606K-231.90%-16.71M-106.90%-342K-453.16%-20.88M-162.18%-222K129.11%4.73M-126.61%-5.04M-86.77%4.95M27.72%5.91M-95.27%357K
Financing cash flow
Cash flow from continuing financing activities 0199.42%24.67M0010.43M14.23M-31.79%8.24M200.72%4.08M105.85%1.52M
Net issuance payments of debt ------0------------------0------------
Net common stock issuance --0190.85%23.95M--0--0--9.72M--14.23M-82.17%8.24M--4.08M--1.52M----
Proceeds from stock option exercised by employees ----35,500.00%712K--0--0----------2K--0--0----
Cash from discontinued financing activities
Financing cash flow --0199.42%24.67M--0--0294.74%10.43M--14.23M-31.79%8.24M200.72%4.08M105.85%1.52M--2.64M
Net cash flow
Beginning cash position 38.12%23.63M-56.11%17.11M90.37%20.41M285.72%48.18M95.62%33.04M-56.11%17.11M113.44%38.99M0.73%10.72M-63.13%12.49M-14.84%16.89M
Current changes in cash -77.57%3.58M130.45%6.64M-49.31%3.25M-1,466.99%-27.77M448.58%15.18M172.29%15.97M-205.23%-21.8M-77.33%6.42M92.38%-1.77M-130.99%-4.36M
Effect of exchange rate changes 83.33%-7K-48.05%-114K-3.85%-27K---9K10.00%-36K-281.82%-42K-1,383.33%-77K-165.00%-26K--0-900.00%-40K
End cash Position -17.64%27.21M38.12%23.63M38.12%23.63M90.37%20.41M285.72%48.18M95.62%33.04M-56.11%17.11M-56.11%17.11M0.73%10.72M-63.13%12.49M
Free cash flow 210.60%3.59M90.37%-2.47M218.45%3.35M20.81%-7.34M163.72%4.77M46.42%-3.25M-118.22%-25.63M48.98%-2.82M-316.46%-9.26M-220.03%-7.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg